Longmont, CO, United States of America

Christopher Shaffer


 

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 76(Granted Patents)


Location History:

  • Boulder, CO (US) (2006)
  • Longmont, CO (US) (2010)
  • Encinitas, CA (US) (2011)

Company Filing History:


Years Active: 2006-2011

Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: Christopher Shaffer: Innovator in Nucleic Acid Technologies

Introduction

Christopher Shaffer is a prominent inventor based in Longmont, CO (US). He has made significant contributions to the field of nucleic acid technologies, holding a total of 4 patents. His work focuses on the synthesis, deprotection, and purification of oligonucleotides and their derivatives.

Latest Patents

Shaffer's latest patents include innovative methods for the deprotection and purification of oligonucleotides. One notable patent details a method for the synthesis, deprotection, and/or purification of nucleic acid molecules, such as siRNA, dsRNA, ribozymes, antisense, and aptamers. Another patent presents a novel approach to the chemical synthesis of oligonucleotides, featuring new compositions, linkers, and derivatized solid supports for efficient solid-phase synthesis of RNA, DNA, and RNA-DNA chimeras.

Career Highlights

Christopher Shaffer is currently associated with Sirna Therapeutics, Inc., where he continues to advance research in nucleic acid technologies. His expertise has led to the development of groundbreaking methods that enhance the efficiency and effectiveness of oligonucleotide synthesis.

Collaborations

Shaffer has collaborated with notable colleagues, including Chandra Vargeese and Weimin Wang, contributing to the advancement of their shared research goals.

Conclusion

Christopher Shaffer's innovative work in nucleic acid technologies has positioned him as a key figure in the field. His patents reflect a commitment to advancing scientific knowledge and practical applications in biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…